Ignite Creation Date:
2025-12-24 @ 1:20 PM
Ignite Modification Date:
2025-12-27 @ 1:47 PM
Study NCT ID:
NCT01768195
Status:
UNKNOWN
Last Update Posted:
2017-01-10
First Post:
2013-01-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy
Sponsor:
Peking University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-01
Start Date Type:
None
Primary Completion Date:
2017-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2017-12
Completion Date Type:
ESTIMATED
First Submit Date:
2013-01-09
First Submit QC Date:
None
Study First Post Date:
2013-01-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-01-08
Last Update Post Date:
2017-01-10
Last Update Post Date Type:
ESTIMATED